The US Nutraceutical Ingredients Market was valued at USD 19,600 Million in 2025 and is projected to reach USD 38,500 Million by 2035, growing at a CAGR of 6.7% from 2024 to 2035.
The economic impact of tariffs on "US Nutraceutical Ingredients Market".
Market Growth Drivers
Increasing consumer awareness regarding preventive healthcare and the rising prevalence of lifestyle-related diseases are significant factors propelling the nutraceutical ingredients market in the US. For example, ADM has heavily invested in R&D to develop functional blends addressing heart health and immunity, responding to consumer demand for products with scientifically backed health claims.
The expansion of functional foods and beverages, driven by changing dietary habits and a focus on personalized nutrition, is further boosting the market. Companies like Cargill have introduced innovative ingredient formulations catering to various health needs, including plant-based proteins and fortified fibers, supporting growth in the nutraceutical sector.
Market Trends
Clean label and natural ingredient trends are shaping the US nutraceutical ingredients market, as consumers increasingly seek products free from artificial additives. Ingredion Inc. recently launched clean label starches and sweeteners, catering to demand for recognizable and trusted ingredients in nutritional supplements and foods.
Technological advancements in encapsulation and delivery systems for nutraceuticals are gaining momentum. Companies such as DuPont Nutrition & Health are developing micro-encapsulation techniques that enhance ingredient stability, bioavailability, and targeted delivery, allowing consumers to experience advanced health benefits more effectively.
Market Opportunities
The growing aging population in the US presents an opportunity for companies to develop targeted nutraceutical solutions for cognitive health, joint support, and immunity, with players such as Kerry Group actively expanding their healthy aging portfolio.
Personalized nutrition is emerging as a major opportunity, with firms like Nestlé Health Science investing in digital platforms and ingredient customization to deliver tailor-made nutraceutical products that cater to unique consumer health profiles.
US Nutraceutical Ingredients Market Revenue (USD Million), 2020-2035
The chart demonstrates a steady upward revenue trajectory for the US nutraceutical ingredients market, from USD 12,800 Million in 2020 to USD 38,500 Million in 2035. Early years show moderate growth, with acceleration beginning post-2024 as factors like heightened consumer health consciousness, innovation in ingredient functionalization, and increased presence of personalized nutrition solutions drive higher adoption across food, beverage, and supplement sectors. The market’s compound annual growth rate (CAGR) of 6.7% reflects the sector’s robust performance against the backdrop of increased preventive health expenditures. The projection highlights significant future expansion opportunities for ingredient manufacturers and formulators.
US Nutraceutical Ingredients Market by Regions Share (%), 2025
According to the 2025 regional market share analysis, the South has the largest share at 34%, underscoring high demand in states like Texas and Florida where demographic diversity and health trends favor nutraceutical adoption. The West, including California, follows with a 26% share, supported by a strong wellness culture and significant industry presence. The Midwest captures 18%, bolstered by manufacturing capacities and increasing health awareness, while the Northeast holds 16% owed to major metropolitan consumers. The rest of the US regions collectively make up 6%, reflecting more gradual adoption trends. Market penetration thus varies by population maturity and regional health trends.
Recent Developments
In March 2024, Cargill announced a strategic partnership with Pharmavite to supply non-GMO plant-based protein blends for a new line of functional dietary supplements focused on heart and muscle health. This partnership aims to integrate Cargill’s proprietary protein technology with Pharmavite’s high-quality supplement manufacturing, accelerating innovative product launches in the US market.
In April 2024, ADM inaugurated a new R&D center in New Jersey dedicated to the development of next-generation nutraceutical ingredients, focusing on adaptive immune support and gut health. This facility empowers ADM to collaborate with startups and academia, fueling pipeline innovation and expediting commercialization of science-based ingredients in the US nutraceutical space.
Ingredion Inc. revealed in May 2024 its acquisition of a prebiotic fiber technology from a biotech startup, enhancing its portfolio in the digestive health segment. This move strengthens Ingredion's competitive position in catering to growing demand for holistic wellness solutions—particularly functional foods and beverages—amid rising consumer health awareness post-pandemic.